Evaluation of the Correlation Between Molecular Phenotype and Radiological Signature (by PET-scanner and MRI) of Incident WHO II and III Grade Gliomas.

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

22 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-09-30

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

From the medical records of a series of patients operated on for incident grade II and III glioma, the primary objective is to evaluate the correlation between the molecular profile of tumours and preoperative imaging data (by FDG and FDOPA PET-scan and multimodal MRI).

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Evaluation of the Use of Radiomics in 18F-FDOPA PET Examinations for the Characterization of Gliomas

NCT04469244

Study on the Use of Radiomics in Gliomas of Initial Disgnosis

COMPLETED

MR Textural Analysis in Low Grade Gliomas

NCT04719806

Glioma

COMPLETED

PET (FDG)-MR Imaging for the Adult Patients Presented With Brain Tumor

NCT02071017

Brain Tumor

UNKNOWN

FET-PET for Diagnosis and Monitoring in Patients With Low Grade Glioma

NCT01089244

Astrocytoma Oligoastrocytoma Oligodendroglioma

UNKNOWN

FET-PET and Multiparametric MRI for High-grade Glioma Patients Undergoing Radiotherapy

NCT03370926

Glioblastoma Multiforme Anaplastic Astrocytoma Radiotherapy

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

A retrospective monocentre study of medical data (clinical, histological, molecular and imaging) contained in the medical records of patients operated on for Grade II or III incident glioma.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Glioma

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_ONLY

Study Time Perspective

RETROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Cohort

Retrospective cohort

Retrospective analysis

Intervention Type OTHER

Evaluate the correlation between tumour molecular profile and preoperative imaging data (FDG and FDOPA PET-scan and multimodal MRI).

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Retrospective analysis

Evaluate the correlation between tumour molecular profile and preoperative imaging data (FDG and FDOPA PET-scan and multimodal MRI).

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Subject 18 years of age or older, having been informed of the research
* Subject operated on with an incident glioma of grade II or III, histologically confirmed (WHO 2016 classification)
* Subject for which all preoperative imaging data is available (MRI, FDG and FDOPA PET-scan)
* Subject for which molecular data of the lesion are available

Exclusion Criteria

* Subject having signified his opposition to the use of his medical data
* Subject under safeguard of justice, guardianship or trusteeship
* Subject with incomplete or missing part of the molecular and/or imaging data

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No